Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

The U.S. Food and Drug Administration (FDA) emphasizes drug product development by Quality by Design (QbD). Critical material attributes (CMAs) are a QbD element that has an impact on pharmaceutical operations and product quality. Pharmaceutical drugs often crystallize as needle-shaped (a CMA) parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Azad, Mohammad A., Capellades, Gerard, Wang, Allison B., Klee, David M., Hammersmith, Gregory, Rapp, Kersten, Brancazio, David, Myerson, Allan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952360/
https://www.ncbi.nlm.nih.gov/pubmed/33709195
http://dx.doi.org/10.1208/s12249-020-01915-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952360/
https://www.ncbi.nlm.nih.gov/pubmed/33709195
http://dx.doi.org/10.1208/s12249-020-01915-6

Ejemplares similares